학술논문

A novel biomarker panel examining response to gemcitabine with or without erlotinib for pancreatic cancer therapy in NCIC Clinical Trials Group PA.3
Document Type
Article
Source
In: PLoS ONE. (PLoS ONE, 1 January 2016, 11(1))
Subject
Language
English
ISSN
19326203